Skip to main content
OpenTrials
Completed

NCT Number: NCT01467674

The Effect Of Glycemic Control On Malondialdehyde, Glutathione Peroxidase, Glutathione And Paraoxonase

The aim of this study was to investigate the impact of glycemic control on clinical periodontal status, levels of malondialdehyde (MDA), glutathione peroxidase (GSH-Px), reduced glutathione (GSH) and paraoxonase (PON) activity in gingival crevicular fluid (GCF) and blood samples of type 2 diabetes mellitus (T2DM) patients with chronic periodontitis (CP).

Completed

Looking for future studies?

Notify Me

Key information

About this study

Reactive oxygen species (ROS) are products of normal cellular metabolism and play beneficial role in physiological functions. Overproduction of ROS and/or deficiency of enzymatic or non-enzymatic antioxidants, termed as oxidative stress, is involved in many pathological conditions such as Diabetes mellitus (DM) and chronic periodontitis (CP).

Several researches revealed that DM, with many determinants such as level of glycemic control, stands as a strong risk factor for periodontal diseases. On the other side, periodontal diseases induce an elevated chronic inflammatory state and exacerbated insulin resistance.

In the present study, the investigators examined the effect of glycemic control level on clinical periodontal status, levels of MDA, GSH-Px, GSH and PON activity in gingival crevicular fluid and blood samples of CP patients with T2DM.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • to present T2DM diagnosis by an endocrinologist for at least the past 5 years
  • diagnosis of CP was based on the clinical and radiographic criteria proposed by the 1999 World Workshop for Classification of Periodontal Diseases and Conditions

Exclusion criteria

  • pregnancy
  • lactation
  • current smoking or smoking within the past 2 years, periodontal therapy in the previous 6 months
  • antibiotic and/or antimicrobial therapies in the previous 3 months
  • existence of serious diabetic complications or any pathology such as haemoglobinopathy which would affect haemoglobin profile
  • diagnosis of another major medical pathology, middle or upper-level obesity according to WHO classification
  • current anti-hyperlipidemic therapy
  • non-T2DM patients with abnormal values of glucose and lipid metabolism parameters, major medical pathology and family history of DM

Treatment and study plan

Primary outcomes

  1. HbA1c

    Time frame: One Year

    Level of Metabolic Control

Secondary outcomes

  1. Clinical Periodontal Status

    Time frame: One Year

    Periodontal indices evaluating clinical periodontal health status

Sponsors and collaborators

Lead sponsor

Suleyman Demirel University

Other

Registry information

Official study title

Malondialdehyde And Antioxidant Levels In Chronic Periodontitis Patients With Type 2 Diabetes Mellitus Under Different Stages Of Metabolic Control

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Nov 9, 2011
Registry last updated
Nov 9, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.